Curi Wealth Management’s ContraFect Corporation CFRX Stock Holding History

Curi Wealth Management’s Portfolio CFRX Stock Details CFRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-1	Closed	–	–	747
2022 Q2	$0	Buy	+1	New	+$282	﹤0.01%	750

Other funds holding CFRX

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

Fosun International Hong Kong, China $399M AUM 16.11% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

PFS

Prospera Financial Services Dallas, Texas $6.89B AUM 37.41% 1-Year Est. Return

AAS

Avantax Advisory Services Dallas, Texas $18.2B AUM 15.06% 1-Year Est. Return

Curi Wealth Management's CFRX Position: Q3 2022 in Review

Curi Wealth Management sold out of ContraFect Corporation (CFRX) in Q3 2022, closing a stake of 1 share.

Curi Wealth Management first reported a position in CFRX in Q2 2022 and held it in 1 quarter. The position peaked at $0 in Q2 2022. 46 funds tracked by Wall St. Rank hold CFRX as of Q3 2022.

Curi Wealth Management reported no remaining ContraFect Corporation position as of Q3 2022 after selling out during the quarter.
Curi Wealth Management sold 1 ContraFect Corporation share in Q3 2022.
Curi Wealth Management first reported a position in ContraFect Corporation in Q2 2022 and held it in 1 quarter.
Curi Wealth Management's ContraFect Corporation position peaked at $0 in Q2 2022.
46 funds tracked by Wall St. Rank held ContraFect Corporation as of Q3 2022.

Based on Curi Wealth Management's 13F filing for Q3 2022, filed 8 Nov 2022.